Suppr超能文献

SARS-CoV-2 感染中的血管炎症和内皮损伤:ACE2 基因簇所涉及的被忽视的调控级联。

Vascular inflammation and endothelial injury in SARS-CoV-2 infection: the overlooked regulatory cascades implicated by the ACE2 gene cluster.

机构信息

From National Heart and Lung Institute, Imperial College London, London, UK.

Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.

出版信息

QJM. 2023 Sep 12;116(8):629-634. doi: 10.1093/qjmed/hcaa241.

Abstract

Coronavirus disease 2019 (COVID-19) has presented physicians with an unprecedented number of challenges and mortality. The basic question is why, in contrast to other 'respiratory' viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can result in such multi-systemic, life-threatening complications and a severe pulmonary vasculopathy. It is widely known that SARS-CoV-2 uses membrane-bound angiotensin-converting enzyme 2 (ACE2) as a receptor, resulting in internalization of the complex by the host cell. We discuss the evidence that failure to suppress coronaviral replication within 5 days results in sustained downregulation of ACE2 protein expression and that ACE2 is under negative-feedback regulation. We then expose openly available experimental repository data that demonstrate the gene for ACE2 lies in a novel cluster of inter-regulated genes on the X chromosome including PIR encoding pirin (quercetin 2,3-dioxygenase), and VEGFD encoding the predominantly lung-expressed vascular endothelial growth factor D. The five double-elite enhancer/promoters pairs that are known to be operational, and shared read-through lncRNA transcripts, imply that ongoing SARS-CoV-2 infection will reduce host defences to reactive oxygen species, directly generate superoxide O2·- and H2O2 (a ' ROS storm'), and impair pulmonary endothelial homeostasis. Published cellular responses to oxidative stress complete the loop to pathophysiology observed in severe COVID-19. Thus, for patients who fail to rapidly suppress viral replication, the newly appreciated ACE2 co-regulated gene cluster predicts delayed responses that would account for catastrophic deteriorations. We conclude that ACE2 homeostatic drives provide a unified understanding that should help optimize therapeutic approaches during the wait until safe, effective vaccines and antiviral therapies for SARS-CoV-2 are delivered.

摘要

新型冠状病毒病 2019(COVID-19)给医生带来了前所未有的挑战和死亡率。基本问题是,与其他“呼吸道”病毒相比,为什么严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染会导致如此多系统的、危及生命的并发症和严重的肺血管病变。众所周知,SARS-CoV-2 使用膜结合的血管紧张素转换酶 2(ACE2)作为受体,导致宿主细胞内化该复合物。我们讨论了未能在 5 天内抑制冠状病毒复制会导致 ACE2 蛋白表达持续下调的证据,并且 ACE2 受到负反馈调节。然后,我们公开了可用的实验存储库数据,这些数据表明 ACE2 的基因位于 X 染色体上一个新的相互调节基因簇中,包括编码吡啉(槲皮素 2,3-双加氧酶)的 PIR 和编码主要在肺部表达的血管内皮生长因子 D 的 VEGFD。已知有五个双精英增强子/启动子对在起作用,并且具有共享的通读长非编码 RNA 转录本,这意味着持续的 SARS-CoV-2 感染将降低宿主对活性氧的防御能力,直接产生超氧化物 O2·-和 H2O2(“ROS 风暴”),并损害肺内皮细胞的稳态。已发表的细胞对氧化应激的反应完成了严重 COVID-19 中观察到的病理生理学循环。因此,对于未能迅速抑制病毒复制的患者,新出现的 ACE2 共同调节基因簇预测会出现延迟反应,这将导致灾难性恶化。我们得出结论,ACE2 稳态驱动提供了一个统一的理解,这应该有助于在等待安全有效的 SARS-CoV-2 疫苗和抗病毒疗法的同时优化治疗方法。

相似文献

引用本文的文献

7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验